Impact of Virtual Reality in Pediatric Hematology and Oncology

• Status: Not yet recruiting
• Trial end date: 2024-04-05
• Target enrollment: 0
• Participant gender: All

Summary

This pilot study will be testing the feasibility of medical hypnosis through virtual reality during invasive médical procédures in children with cancer. Patients age from 7 to under 18 years whose treatement protocols required a lumbure puncture and a chemotherapy by implantable venous access will be randomly assigned to virtual reality or treatement as usual (nitrous oxide, anxiolytics, opioid analgesics, psychotropic and benzodiazepine). We expect the same benefit by using VR as usual intervention.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Poitiers University Hospital

Criteria

Inclusion Criteria:

• Patients aged 7 to strictly under 18

• Follow-ups for hematological or oncological pathology

• With a lumbar puncture

• Patient understanding French

• Consent of parents or guardians with parental authority.

• Child informed and having given his assent

Exclusion Criteria:

• Children with cognitive impairment

• Children with maintenance treatment

• Children in absolute emergency situations

• Children with a contraindication to a virtual reality headset (psychiatric pathology, vestibular and proprioceptive disorders, unbalanced epilepsy, impaired vision, hearing aids, claustrophobia, recent lesions of the eyes, face or scalp)

• Children who have already participated in the clinical investigation

• Refusal to participate in the study

• Patients not benefiting from a social security system or not benefiting from it by the intermediary of a third person